New hope for painful skin condition: drug trial targets severe lichen planus
NCT ID NCT07492251
First seen Mar 26, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tests a daily pill called upadacitinib for people with severe forms of lichen planus, a chronic skin condition causing painful mouth sores or hair loss. About 56 adults will receive either the drug or a placebo for 16 weeks to see if it reduces symptoms. The goal is to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LICHEN PENIS PLANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
APHP
Paris, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
CHU de Nice
Nice, Alpes Maritimes, 06200, France
Contact Email: •••••@•••••
Contact
-
CHU de Rouen
Rouen, France
Contact Email: •••••@•••••
Contact
-
CHU de Tours
Tours, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre privé de Dermatologie
Reims, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.